The clinical development of obinutuzumab for the treatment of follicular lymphoma

Barbara Ma,1 Chaitra Ujjani2 1Department of Medicine, 2Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, USA Abstract: Impressive progress has been made in recent decades for advanced-stage follicular lymphoma with the availability of anti-CD20 monoclonal...

Full description

Bibliographic Details
Published in:Cancer Management and Research
Main Authors: Ma B, Ujjani C
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Subjects:
follicular lymphoma
obinutuzumab
anti-CD20 monoclonal antibody
Online Access:https://www.dovepress.com/the-clinical-development-of-obinutuzumab-for-the-treatment-of-follicul-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/the-clinical-development-of-obinutuzumab-for-the-treatment-of-follicul-peer-reviewed-article-CMAR

Similar Items